IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Venrock Adviser, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 27 holdings | $154.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$78.7M4,563,96250.8%
Celldex Therapeutics Inc(CLDX)COM15117B202$29.5M865,11619.0%
Aadi Bioscience Inc(WHWK)COM00032Q104$26.0M1,529,40216.8%
Cogent Biosciences Inc(COGT)COM19240Q201$8.2M1,088,8175.3%
aTyr Pharma Inc(ATYR)COM002120202$7.5M1,398,8894.8%
Altimmune Inc(ALT)COM02155H200$4.6M759,7193.0%
Instil Bio IncCOM45783C101$73.8K6,865,0760.0%
Relmada Therapeutics Inc(RLMD)COM75955J402$61.3K2,270,0720.0%
Travere Therapeutics Inc(TVTX)COM89422G107$51.4K1,994,9970.0%
GH Research PLC(GHRS)ORD SHG3855L106$37.5K2,051,0600.0%
Tricida Inc(1T7)COM89610F101$36.9K4,494,8510.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$34.3K1,852,9190.0%
Marinus Pharmaceuticals Inc(MRNS*)COM56854Q200$29.5K3,156,8030.0%
Chinook Therapeutics Inc(290A)COM16961L106$21.0K1,283,8210.0%
LianBioSPONS ADR53000N108$20.0K5,378,3410.0%
VistaGen Therapeutics Inc(VTGNUSD)COM92840H202$19.9K16,047,2860.0%
Athira Pharma IncCOM04746L104$13.5K1,000,0000.0%
Eiger BioPharmaceuticals Inc(CLDNEUR)COM28249U105$12.2K1,469,7670.0%
Nuvalent Inc(NUVL)COM670703107$11.2K803,9510.0%
Graphite Bio Inc(GRPH)COM38870X104$8.2K1,612,6170.0%
Provention Bio Inc(PRVBUSD)COM74374N102$8.2K1,118,6530.0%
Affimed NVCOMN01045108$6.2K1,428,5710.0%
Sierra Oncology IncCOM82640U404$5.2K162,4790.0%
Centessa Pharmaceuticals PLC(CNTA)SPONS ADR152309100$3.7K411,3610.0%
Astria Therapeutics Inc(CATBUSD)COM04635X102$3.6K538,9990.0%
Aerovate Therapeutics IncCOM008064107$2.8K151,0370.0%
Savara Inc(SVRA)COM805111101$2.5K1,905,2650.0%